CIS BIOPHARMA is the Basel-based 2023 oncology spinoff from CIS Pharma. Christoph Schäfer,CEO of CIS Pharma, talks about his...

Backed by 3Biotech, Nantes-based start-up Abcely, which offers a unique approach to the treatment of mucosal cancers, ...

Karla Therapeutics is the first "T cell company" aiming to improve mental health. Its drug development program relies ...

Epynext Therapeutics is dedicated to the fight against antibiotic resistance, one of the most urgent health threats of our time ...

Interview with Gilles Avenard, co-founder and CEO of Acticor Biotech...

Interview with Thierry Bernardi, President of BioFilm Control